Unlike IV therapy or injections, these products are applied externally and work primarily on the upper layers of the skin
While semaglutide will remain under patent in many regions until the early 2030s, the first generic versions are expected to launch in India imminently, with additional market entries anticipated in China, Canada, Brazil, Turkey, and South Africa in the months that follow
Together, they promote fat metabolism, improve energy, and support liver function
Cardiovascular considerations : Saxenda has been associated with increased heart rate in some patients
Using unapproved substances not only jeopardizes individual health but also raises ethical and legal issues, especially when medical professionals are involved
While compounded formulations are prepared in FDA-regulated pharmacies, the FDA does not verify their safety or effectiveness